Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW., Staplin N., Peto L., Emberson JR., Campbell M., Pessoa-Amorim G., Basnyat B., Thwaites L., Van Doorn R., Hamers RL., Nel J., Amuasi J., Stewart R., Ghosh D., Hamilton F., Desai P., Easom N., Majumdar J., Hine P., Chadwick D., Cooke G., Sharp S., Esmail H., Baillie JK., Buch MH., Faust SN., Jaki T., Jeffery K., Juszczak E., Knight M., Lim WS., Montgomery A., Mukherjee A., Mumford A., Rowan K., Thwaites G., Mafham M., Haynes R., Landray MJ.

DOI

10.1101/2024.05.23.24307731

Type

Publication Date

24/05/2024

Permalink Original publication